Welshare Health Introduces AI-Driven App to Inaugurate the Future of Patient-Driven Medical Research

Welshare
Health,
an
industry-leading
company
in
the
DeSci
(Decentralized
Science)
space,
revealed
it
is
developing
the
first
decentralized
application
empowering
individuals
to
contribute
to
AI-driven
medical
research.
The
app
is
built
on
Base
and
helps
patients
gain
more
control
over
their
health
data
while
personalizing
their
contributions
to
medical
studies.
The
developers
claim
the
Welshare
Health
app
has
the
potential
to
revolutionize
how
medical
research
is
conducted
and
healthcare
is
delivered.

Welshare
Health
launched
the
initial
closed
beta
version
of
the
dApp
in
May
2024.
The
application
uses
DeSci
to
harness
the
combined
power
of
AI-driven
medical
research
and
Web3
technologies.
Decentralized
Science
is
an
emerging
field
that
uses
blockchain
and
other
decentralized
technologies
to
democratize
scientific
research.
While
the
app
is
still
in
closed
beta
testing,
prospective
users
can
sign
up
for
the
exclusive
waiting
list
to
gain
early
access.

Welshare
Health
believes
traditional
medical
research
is
slow
and
faces
significant
challenges
primarily
because
it
has
limited
access
to
diverse
datasets.
Allegedly,
medical
research
companies
spend
up
to
$600
billion
yearly
on
data
silos
due
to
outdated
clinical
trial
recruitment
and
the
lack
of
patient
behavior
insights.
Meanwhile,
patients
have
little
control
over
how
companies
use
their
health
data,
thus
benefitting
very
little
from
participating
in
research
studies.

The
Welshare
Health
application
eliminates
intermediaries
and
connects
patients
directly
with
medical
research.
As
a
result,
it
enables
individuals
to
control
their
health
data
and
helps
medical
research
organizations
tackle
the
$600
billion
health
data
market
problem.
The
company
leverages
Web3
technologies,
such
as
blockchain-based
smart
contracts,
that
secure
data
processing,
ownership,
and
monetization
while
keeping
information
private.

The
app
will
initially
focus
on
diabetes
research,
connecting
users
to
research
initiatives
through
the
company’s
partners
in
diabetes
patient
advocacy
groups.
Nevertheless,
the
developers
encourage
individuals
to
sign
up
and
complete
a
medical
questionnaire
even
if
they
do
not
have
diabetes.
Their
data
will
help
expand
the
app’s
database
as
it
moves
into
other
therapeutic
areas.

The
Welshare
Health
team
is
aware
of
the
many
challenges
that
individuals
living
with
type
1
diabetes
(T1D)
face,
including
non-personalized
AID
systems.
This
issue
prevents
them
from
effectively
addressing
the
diverse
physiological
and
lifestyle
factors
influencing
blood
glucose
dynamics.
Some
of
these
problems
include
frustration,
anxiety,
and
an
increased
burden
of
disease
management.

Welshare
Health
aims
to
solve
these
issues
via
AI
integration
in
developing
hyper-personalized
algorithms
capable
of
revolutionizing
AID
technology.
These
algorithms
would
personalize
insulin
delivery,
implement
predictive
analytics,
leverage
adaptive
learning,
and
integrate
other
components,
such
as
wearables,
of
the
broader
digital
health
ecosystem.

Welshare
Health
combines
DeSci
and
AI
within
its
app
to
transform
patients’
lives
and
give
them
more
control
over
their
medical
issues.
In
the
app’s
dynamic
ecosystem,
individuals
become
active
participants
in
medical
research
rather
than
passive
data
contributors.
The
app
uses
decentralized
governance
mechanisms
and
smart
contracts
to
incentivize
users
to
share
their
data
ethically
and
responsibly
while
ensuring
a
fair
and
equitable
distribution
of
rewards.

About
Welshare
Health

Welshare
Health
boasts
a
strong
network
in
both
the
pharmaceutical
and
Web3
sectors.
The
company
combines
traditional
healthcare
expertise
with
cutting-edge
decentralized
technology
to
provide
a
unique
application
bridging
individuals
with
the
future
of
medical
research.
The
app’s
AI-driven
insights
empower
users
to
make
informed
decisions
about
their
health.
This
approach
drives
proactive
engagement
in
preventive
care
and
disease
management.

The
team
consists
of
healthcare
experts
with
over
a
decade
of
experience
in
top-10
Pharmaceutical
and
hospital
institutions,
including
Sanofi
and
Charité.
Other
members
of
the
Welshare
Health
team
include
blockchain
experts,
mobile
app
developers,
advisors
in
business
development
and
marketing,
and
technical
and
patient
community
leaders.
According
to
the


project’s
whitepaper,
together
they
share
the
vision
of “a
world
where
everyone
can
actively
participate
in
advancing
medical
knowledge
and
improving
healthcare
outcomes.”

You
can
learn
more
about
Welshare
Health
and
stay
up-to-date
with
its
developments
here: Website
| X
(Twitter)
| Telegram
| Discord